Optical control of antibody activity using photocleavable bivalent peptide-DNA locks

Simone Wouters, E. Wijker, Maarten Merkx (Corresponding author)

Research output: Contribution to journalArticleAcademicpeer-review

2 Citations (Scopus)
11 Downloads (Pure)

Abstract

Antibody-based molecular recognition plays a central role in today's life sciences, ranging from immunoassays to molecular imaging and antibody-based therapeutics. Control over antibody activity by using external triggers such as light could further increase the specificity of antibody-based targeting. Here we present bivalent peptide–DNA ligands containing photocleavable linkers as a noncovalent approach by which to allow photoactivation of antibody activity. Light-triggered cleavage of the 3-amino-3-(2-nitrophenyl)propionic acid peptide linker converted the high-affinity bivalent peptide–DNA lock into weakly binding monovalent ligands, effectively restoring antibody targeting of cell-surface receptors. In this work, a proof of principle was provided with an anti-hemagglutinin antibody, but the molecular design of the lock is generic and applicable to any monoclonal antibody for which an epitope or mimotope of sufficient affinity is available.

Original languageEnglish
Pages (from-to)2463-2466
Number of pages4
JournalChemBioChem
Volume20
Issue number19
DOIs
Publication statusPublished - 1 Oct 2019
Event1st International Workshop on Metals in Medicine: Chimie ParisTech - Paris, France
Duration: 14 Nov 201915 Nov 2019

Fingerprint

Peptides
Antibodies
DNA
Ligands
Light
Molecular Imaging
Antibody Specificity
Biological Science Disciplines
Hemagglutinins
Cell Surface Receptors
Immunoassay
Molecular imaging
Molecular recognition
Epitopes
Anti-Idiotypic Antibodies
Monoclonal Antibodies
Therapeutics

Keywords

  • antibodies
  • bivalent ligands
  • caged ligands
  • optogenetics
  • photolysis

Cite this

@article{1c2206475eb64e04a239e7676abc010a,
title = "Optical control of antibody activity using photocleavable bivalent peptide-DNA locks",
abstract = "Antibody-based molecular recognition plays a central role in today's life sciences, ranging from immunoassays to molecular imaging and antibody-based therapeutics. Control over antibody activity by using external triggers such as light could further increase the specificity of antibody-based targeting. Here we present bivalent peptide–DNA ligands containing photocleavable linkers as a noncovalent approach by which to allow photoactivation of antibody activity. Light-triggered cleavage of the 3-amino-3-(2-nitrophenyl)propionic acid peptide linker converted the high-affinity bivalent peptide–DNA lock into weakly binding monovalent ligands, effectively restoring antibody targeting of cell-surface receptors. In this work, a proof of principle was provided with an anti-hemagglutinin antibody, but the molecular design of the lock is generic and applicable to any monoclonal antibody for which an epitope or mimotope of sufficient affinity is available.",
keywords = "antibodies, bivalent ligands, caged ligands, optogenetics, photolysis",
author = "Simone Wouters and E. Wijker and Maarten Merkx",
year = "2019",
month = "10",
day = "1",
doi = "10.1002/cbic.201900241",
language = "English",
volume = "20",
pages = "2463--2466",
journal = "ChemBioChem",
issn = "1439-4227",
publisher = "Wiley-VCH Verlag",
number = "19",

}

Optical control of antibody activity using photocleavable bivalent peptide-DNA locks. / Wouters, Simone; Wijker, E.; Merkx, Maarten (Corresponding author).

In: ChemBioChem, Vol. 20, No. 19, 01.10.2019, p. 2463-2466.

Research output: Contribution to journalArticleAcademicpeer-review

TY - JOUR

T1 - Optical control of antibody activity using photocleavable bivalent peptide-DNA locks

AU - Wouters, Simone

AU - Wijker, E.

AU - Merkx, Maarten

PY - 2019/10/1

Y1 - 2019/10/1

N2 - Antibody-based molecular recognition plays a central role in today's life sciences, ranging from immunoassays to molecular imaging and antibody-based therapeutics. Control over antibody activity by using external triggers such as light could further increase the specificity of antibody-based targeting. Here we present bivalent peptide–DNA ligands containing photocleavable linkers as a noncovalent approach by which to allow photoactivation of antibody activity. Light-triggered cleavage of the 3-amino-3-(2-nitrophenyl)propionic acid peptide linker converted the high-affinity bivalent peptide–DNA lock into weakly binding monovalent ligands, effectively restoring antibody targeting of cell-surface receptors. In this work, a proof of principle was provided with an anti-hemagglutinin antibody, but the molecular design of the lock is generic and applicable to any monoclonal antibody for which an epitope or mimotope of sufficient affinity is available.

AB - Antibody-based molecular recognition plays a central role in today's life sciences, ranging from immunoassays to molecular imaging and antibody-based therapeutics. Control over antibody activity by using external triggers such as light could further increase the specificity of antibody-based targeting. Here we present bivalent peptide–DNA ligands containing photocleavable linkers as a noncovalent approach by which to allow photoactivation of antibody activity. Light-triggered cleavage of the 3-amino-3-(2-nitrophenyl)propionic acid peptide linker converted the high-affinity bivalent peptide–DNA lock into weakly binding monovalent ligands, effectively restoring antibody targeting of cell-surface receptors. In this work, a proof of principle was provided with an anti-hemagglutinin antibody, but the molecular design of the lock is generic and applicable to any monoclonal antibody for which an epitope or mimotope of sufficient affinity is available.

KW - antibodies

KW - bivalent ligands

KW - caged ligands

KW - optogenetics

KW - photolysis

UR - http://www.scopus.com/inward/record.url?scp=85071644648&partnerID=8YFLogxK

U2 - 10.1002/cbic.201900241

DO - 10.1002/cbic.201900241

M3 - Article

C2 - 31074548

VL - 20

SP - 2463

EP - 2466

JO - ChemBioChem

JF - ChemBioChem

SN - 1439-4227

IS - 19

ER -